an expert team from the EMAV membership experienced in development, manufacturing and regulation of autogenous vaccines, supportive in the evaluation of all scientific issue relevant for EMAV
founded in September 2019
activities coordinated by Wiebke Bielenberg (SAN Group Biotech Germany)
Get to know the members of our Scientific Working Group!
introduced for the definition of basic requirements for the target-oriented use of autogenous vaccine by Vet professionals in different species in an European harmonized market, focussed on the appropriate usage of autogenous vaccines under field conditions
established in May 2020
headed by Maarten de Gussem (Poulpharm), member of the EMAV Board
We introduce the members of our Practice Advisory Group.
